Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hubert Drepper is active.

Publication


Featured researches published by Hubert Drepper.


Cancer | 1995

Primary cutaneous melanoma. Prognostic classification of anatomic location

Claus Garbe; Petra Buttner; Jochen Bertz; Günter Burg; Barbara D'Hoedt; Hubert Drepper; Irene Guggenmoos-Holzmann; Walter Lechner; Andrea Lippold; Constantin E. Orfanos; Almut Peters; Gernot Rassner; Rudolf Stadler; Waltraud Stroebel

Background. Anatomic location has been identified by several investigators as a significant prognostic factor for patients with primary cutaneous melanoma (CM). However, the best determination of higher and lower risk sites is still controversial, and the biologic significance of tumor site in the course of primary CM is unknown. The aim of the present study was to identify higher and lower risk sites based on multivariate analysis.


Cancer | 1993

The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheide

Hubert Drepper; Brigitte Bieß; Brigitte Hofherr; Max Hundeiker; Andrea Lippold; Friedrich Otto; Gisela Padberg; Almut Peters; Hans Wiebelt

Background. Prognostic factors for patients with stage III melanoma are still controversial.


Oncology | 1991

DNA Flow Cytometry in the Prognosis of Primary Malignant Melanoma

Detlef Bartkowiak; Johannes Schumann; Friedrich Otto; Andrea Lippold; Hubert Drepper

DNA flow cytometry was carried out on 804 primary melanomas. The data were analyzed with a follow-up of 24-96 months. 57% of the cases were diploid, 32% had one abnormal cell population, and 11% were multiclonal. In 8% of the aneuploid tumors there were cell lines in the hypertetraploid range. A reliable S phase determination was possible in 524 cases. Among these 11% had an S phase exceeding 15%. Using an increased tumor thickness, relapse rate and mortality as criteria of tumor progression, aneuploidy and multiclonality, the occurrence of hypertetraploid cell lines and a high S phase (greater than 15%) proved to be correlated with a poor prognosis.


Oncology | 1991

Sequential DNA Flow Cytometry in Metastatic Malignant Melanoma

Detlef Bartkowiak; Friedrich Otto; Johannes Schumann; Andrea Lippold; Hubert Drepper

Sequential flow cytometry was performed on 73 metastatic malignant melanomas, derived from 804 primary tumors. Tumor thickness was confirmed an excellent prognostic parameter in primary melanoma, but did not allow reliable predictions in metastatic disease. Also, aneuploidy and genetic heterogeneity, both common in metastatic melanoma, were equally distributed among patients differing in survival time. However, a remarkable acceleration was observed in the generation of abnormal cell lines in patients dying early of metastatic disease.


Hautarzt | 1994

Is the acral-lentiginous melanoma (ALM) more malignant than the superficial spreading melanoma (SSM) in a high-risk location? A matched-pair comparison of 113 each ALM and SSM in a multicenter study

Helmut Breuninger; Claus O. Köhler; Hubert Drepper; Boris C. Bastian; Eva-B. Bröcker; J. Göhl; Wolfgang Groth; Paul Hermanek; Werner Hohenberger; Andrea Lippold; Klaus F. Kölmel; Michael Landthaler; Almut Peters; Wolfgang Tilgen

Zusammenfassung. Die Prognose des akrolentiginösen Melanoms (ALM) wird auch heute noch kontrovers beurteilt. Diese große Fallstudie schließt deshalb alle bekannten prognoserelevanten Faktoren ein. Aus einem Kollektiv von 3616 Melanomen wurden den vorhandenen 113 ALM genau 113 Symptom-Zwillinge des superfiziell spreitenden Melanoms (SSM) aus einer 619 Fälle umfassenden high-risk-Lokalisationgruppe zugeordnet, die sich in Tumordicke, Geschlecht und Behandlungsmodalität glichen. Die Nachbeobachtung betrug mindestens 5 Jahre. Die 5-Jahres-Überlebenskurven nach Kaplan-Meier der beiden Gruppen unterschieden sich nicht. Die oftmals beschriebene schlechtere Prognose des ALM ist eine Folge der Lokalisation und nicht des Typs. Das ALM ist demnach als akral lokalisiertes Melanom zu betrachten.Abstract. Even today, the prognosis of acral-lentiginous melanoma (ALM) remains a controversial topic. We present a large case study including all known factors relevant for prognosis. 113 ALMs in 3616 melanoma patients were paired as precisely as possible with their twins, i.e. with 113 superficial spreading melanomas (SSM) from a group of 619 SSMs with high-risk location. The ALMs and SSMs were equivalent in tumor thickness, patient gender and mode of treatment. The follow-up period was for at least 5 years. The 5-year Kaplan-Meier survival curves in both groups are identical. The poor prognosis often ascribed to ALM results from the prognostic factor location. ALM should therefore be regarded as acral localized melanoma.


Archive | 1984

Validierung der TNM-Klassifikation des Malignen Melanoms — Zwischenergebnisse der Hornheider Melanomstudie —

Andrea Lippold; Hubert Drepper; Karla Höcker-Lindemann

In der Fachklinik Hornheide wird auf Anregung der UICC mit Unterstutzung der Bundesregierung eine prospektive Feldstudie zur Validierung des TNM-Systems beim ‘Malignen Melanom’ durchgefuhrt.


Archive | 1993

Benefit of Elective Lymph Node Dissection in Subgroups of Melanoma Patients

Hubert Drepper; Boris C. Bastian; Helmut Breuninger; Ej Eva-B; J. Göhl; Wolfgang Groth; Paul Hermanek; B Werner Hohenberger; Andrea Lippold; Klaus F. Kölmel; Michael Landthaler; Wolfgang Tilgen


Hautarzt | 1994

Ist das akrolentiginöse Melanom (ALM) maligner als das superfiziell spreitende Melanom (SSM) in einer High-risk-Lokalisation ?

Helmut Breuninger; Claus O. Köhler; Hubert Drepper; Boris C. Bastian; Eva-B. Bröcker; J. Göhl; Wolfgang Groth; Paul Hermanek; Werner Hohenberger; Andrea Lippold; Klaus F. Kölmel; Michael Landthaler; Almut Peters; Wolfgang Tilgen


Hautarzt | 1994

[Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].

Helmut Breuninger; Claus O. Köhler; Hubert Drepper; Boris C. Bastian; Eva-B. Bröcker; J. Göhl; Wolfgang Groth; Paul Hermanek; Werner Hohenberger; Andrea Lippold


Hautarzt | 1994

[Prognostic advantage for defined risk groups by lymphocyte dissection. Long-term study of 3,616 melanoma patients].

Hubert Drepper; Claus O. Köhler; Boris C. Bastian; Helmut Breuninger; Eva-B. Bröcker; J. Göhl; Wolfgang Groth; Paul Hermanek; Werner Hohenberger; Klaus F. Kölmel

Collaboration


Dive into the Hubert Drepper's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Göhl

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

Paul Hermanek

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Werner Hohenberger

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claus Garbe

University of Tübingen

View shared research outputs
Researchain Logo
Decentralizing Knowledge